TeraRecon
Private Company
Total funding raised: $25M
Overview
TeraRecon, founded in 1997 and headquartered in Durham, North Carolina, is a leader in AI-driven advanced visualization for medical imaging. The company's core platform integrates clinical AI algorithms into a unified, subscription-based software suite to streamline diagnostic workflows and support decision-making across hospital systems. As part of ConcertAI's imaging solutions, TeraRecon focuses on enabling the adoption of reimbursable AI biomarkers and consolidating disparate 3D and AI tools into a single, scalable enterprise platform. Its solutions are designed to improve time-to-treatment, increase throughput, and enhance patient outcomes.
Technology Platform
SaaS-based advanced medical imaging visualization platform with an open architecture for integrating third-party and proprietary AI algorithms. Includes enterprise-scale AI deployment and management tools (TeraRecon DETECT) and interactive, human-in-the-loop AI workflow integration.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
TeraRecon competes in a crowded field including large, integrated device manufacturers (GE HealthCare, Siemens Healthineers, Philips) who offer advanced visualization and AI, as well as pure-play software and AI companies like Aidoc, Viz.ai, and HeartFlow. Its key differentiation is its position as an open, enterprise-scale platform for consolidating and managing multiple AI applications, rather than a single-point solution.